StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
101
This month
1
This year
1
Publishing Date
2022 - 05 - 31
2
2022 - 05 - 17
1
2022 - 04 - 28
1
2022 - 04 - 14
1
2022 - 04 - 07
1
2022 - 03 - 21
1
2022 - 02 - 24
1
2022 - 02 - 22
1
2022 - 02 - 21
1
2022 - 02 - 16
1
2022 - 01 - 31
2
2022 - 01 - 10
1
2021 - 12 - 10
2
2021 - 12 - 09
1
2021 - 11 - 19
1
2021 - 11 - 17
1
2021 - 11 - 09
1
2021 - 10 - 25
1
2021 - 10 - 14
1
2021 - 10 - 12
1
2021 - 10 - 06
1
2021 - 10 - 05
1
2021 - 09 - 24
1
2021 - 09 - 08
1
2021 - 09 - 07
1
2021 - 08 - 25
1
2021 - 08 - 16
2
2021 - 08 - 13
1
2021 - 08 - 09
1
2021 - 08 - 06
1
2021 - 08 - 03
1
2021 - 07 - 23
1
2021 - 07 - 22
2
2021 - 07 - 12
1
2021 - 06 - 29
1
2021 - 06 - 14
1
2021 - 06 - 10
1
2021 - 06 - 07
2
2021 - 06 - 01
1
2021 - 05 - 24
1
2021 - 05 - 17
1
2021 - 05 - 12
1
2021 - 05 - 03
1
2021 - 04 - 29
1
2021 - 04 - 27
1
2021 - 04 - 26
1
2021 - 04 - 20
1
2021 - 04 - 15
1
2021 - 04 - 06
1
2021 - 04 - 01
1
2021 - 03 - 22
1
2021 - 03 - 08
1
2021 - 02 - 24
2
2021 - 02 - 11
1
2021 - 02 - 09
1
2021 - 02 - 03
2
2021 - 01 - 27
1
2020 - 12 - 30
1
2020 - 12 - 18
1
2020 - 12 - 08
1
Sector
Commercial services
1
Consumer services
1
Electronic technology
1
Energy minerals
1
Health care and social assistance
1
Health technology
101
Non-energy minerals
1
Process industries
1
Producer manufacturing
1
Professional, scientific, and technical services
1
Technology services
2
Utilities
1
Tags
Agreement
3
Alliances
10
Antibody
1
Application
4
Approval
4
Australia
1
Authorization
10
Authorized
9
Biopharma
2
Biotechnology
20
Cancer
3
Children
7
Chmp
2
Clinical-trials-phase-ii
3
Collaboration
4
Covid
42
Covid-19
35
Designation
2
Disease
2
Drug
4
Ema
5
Emergency use authorization
3
Europe
5
Fda
11
Fda-approvals
3
Genetown
24
Global
3
Grant
2
Granted
3
Health
5
Japan
4
Keytruda
2
License
2
Meeting
2
Merck
2
Merge
5
Mrna
9
N/a
10
Order
3
Partnership
2
Pharmaceutical
2
Phase 1
3
Phase 2
3
Phase 3
3
Platform
4
Positive
3
Product-news
9
Regulatory
2
Research
14
Respiratory
4
Rna-3927
3
Rna-4157
2
Study
2
Submission
3
Switzerland
4
Technology
2
Therapy
4
Treatment
2
Vaccine
66
Virus
2
Entities
Amicus therapeutics, inc.
1
Baxter international inc.
1
Biontech se
1
Catalent, inc.
2
Charles river laboratories international, inc.
1
Curevac n.v.
1
Danaher corporation
1
Denali therapeutics inc.
2
Dynavax technologies corporation
1
Evelo biosciences, inc.
2
Foghorn therapeutics inc.
2
Glaxosmithkline plc
1
International business machines corporation
1
Johnson & johnson
2
Lonza group ag
1
Merck & company, inc.
3
Mks instruments, inc.
1
Moderna, inc.
101
Modivcare inc
1
Msci inc
1
Mueller industries, inc.
1
Netflix, inc.
1
Neurocrine biosciences, inc.
1
Newmont corporation
1
Novavax, inc.
1
Nrg energy, inc.
1
Nutanix, inc.
1
Nutrien ltd.
1
Oge energy corp
1
Olympic steel, inc.
1
Omega therapeutics inc
2
Omnicell, inc.
1
Ovintiv inc.
1
Par pacific holdings, inc.
1
Paycom software, inc.
1
Paypal holdings, inc.
1
Pfizer, inc.
1
Pinterest, inc.
1
Qiagen n.v.
1
Qualcomm incorporated
1
Rayonier advanced materials inc.
1
Regeneron pharmaceuticals, inc.
1
Renewable energy group, inc.
1
Sana biotechnology inc
2
Sangamo therapeutics, inc.
1
Sanofi
2
Seres therapeutics, inc.
2
Sierra oncology, inc.
1
Sorrento therapeutics, inc.
1
Takeda pharmaceutical company limited
3
Thermo fisher scientific inc
2
Translate bio, inc.
1
Symbols
AAPL
192
ABB
220
ABBV
235
ABLZF
207
ABT
287
AMGN
116
ARVL
715
AZN
119
BDX
122
BMO
183
BMY
186
BNPQF
150
BNPQY
150
CM
116
CSCO
201
CSSE
134
DSX
131
DUK
116
ERIC
276
FE
109
FNCTF
1246
GE
151
GILD
110
GOOG
139
GOOGL
141
GSK
144
HON
254
HUBS
220
INCY
154
INTC
183
IT
381
JNJ
811
LLY
410
LTUM
142
MDT
246
MMM
156
MRK
143
MS
464
MSFT
189
NVDA
130
NVS
198
NVSEF
166
ORCL
203
PCRFF
112
PCRFY
112
PFE
200
PHG
118
PPRUF
169
PPRUY
169
REGN
144
RY
136
SAP
256
SAPGF
228
SNOW
117
SNY
902
SNYNF
742
TAK
119
TEVJF
152
TMO
267
VZ
203
Exchanges
Nasdaq
101
Nyse
15
Crawled Date
2023 - 05 - 04
2
2022 - 05 - 31
2
2022 - 05 - 17
1
2022 - 04 - 28
1
2022 - 04 - 14
1
2022 - 04 - 07
1
2022 - 03 - 21
1
2022 - 02 - 24
1
2022 - 02 - 22
1
2022 - 02 - 21
1
2022 - 02 - 16
1
2022 - 01 - 31
2
2022 - 01 - 10
1
2021 - 12 - 10
3
2021 - 11 - 19
1
2021 - 11 - 17
1
2021 - 11 - 09
1
2021 - 10 - 25
1
2021 - 10 - 14
1
2021 - 10 - 12
1
2021 - 10 - 06
1
2021 - 10 - 05
1
2021 - 09 - 24
1
2021 - 09 - 08
1
2021 - 09 - 07
1
2021 - 08 - 25
1
2021 - 08 - 16
2
2021 - 08 - 13
1
2021 - 08 - 09
1
2021 - 08 - 06
1
2021 - 08 - 03
1
2021 - 07 - 23
1
2021 - 07 - 22
2
2021 - 07 - 12
1
2021 - 06 - 29
1
2021 - 06 - 14
1
2021 - 06 - 10
1
2021 - 06 - 07
2
2021 - 06 - 01
1
2021 - 05 - 24
1
2021 - 05 - 17
1
2021 - 05 - 12
1
2021 - 05 - 03
1
2021 - 04 - 29
1
2021 - 04 - 27
1
2021 - 04 - 26
1
2021 - 04 - 20
1
2021 - 04 - 15
1
2021 - 04 - 06
1
2021 - 04 - 01
1
2021 - 03 - 22
1
2021 - 03 - 08
1
2021 - 02 - 24
2
2021 - 02 - 11
1
2021 - 02 - 10
1
2021 - 02 - 03
2
2021 - 01 - 27
1
2020 - 12 - 30
1
2020 - 12 - 18
1
2020 - 12 - 08
1
Crawled Time
00:00
3
07:00
1
08:00
1
09:00
4
10:00
2
11:00
4
12:00
14
12:15
1
12:30
1
13:00
12
13:15
2
13:20
2
13:30
1
14:00
13
14:15
3
14:30
3
15:00
3
15:15
2
15:20
1
16:00
6
16:29
1
17:00
4
18:00
4
19:00
4
20:00
1
21:00
1
22:00
2
23:00
5
Source
www.biospace.com
91
www.catalent.com
1
www.prnewswire.com
9
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
for
symbols :
Mrna
save search
Phase 1/2 Interim Data on Moderna’s mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia, Published in Nature
Published:
2024-04-03
(Crawled : 19:00)
- biospace.com/
MRNA
S
|
$101.44
-0.55%
-0.55%
2.6M
|
Health Technology
|
-2.12%
|
O:
-0.59%
H:
2.09%
C:
-1.74%
rna-3927
mrna
therapy
Moderna Announces Changes to Commercial Organization to Prepare for Multiple Product Launches in 2024 and 2025
Published:
2023-12-12
(Crawled : 14:00)
- biospace.com/
MRNA
S
|
$101.44
-0.55%
-0.55%
2.6M
|
Health Technology
|
23.67%
|
O:
-0.93%
H:
0.18%
C:
-3.94%
commercial
Merck and Moderna Initiate INTerpath-002, a Phase 3 Study Evaluating V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) for Adjuvant Treatment of Patients with Certain Types of Resected Non-Small Cell Lung Cancer
Published:
2023-12-11
(Crawled : 14:30)
- biospace.com/
MRK
|
News
|
$125.78
0.44%
0.0%
8.4M
|
Health Technology
|
21.23%
|
O:
1.06%
H:
0.59%
C:
-0.46%
MRNA
S
|
$101.44
-0.55%
-0.55%
2.6M
|
Health Technology
|
26.26%
|
O:
-0.47%
H:
3.28%
C:
2.58%
rna-4157
keytruda
lung
merck
cancer
cell
treatment
study
Moderna Tops BioSpace’s Best Places to Work Ranking for Third Consecutive Year
Published:
2023-11-07
(Crawled : 14:00)
- biospace.com/
MRNA
S
|
$101.44
-0.55%
-0.55%
2.6M
|
Health Technology
|
40.71%
|
O:
0.21%
H:
2.08%
C:
1.99%
work
year
Carisma Presents Pre-Clinical Proof of Concept for in vivo CAR-M using mRNA platform in collaboration with Moderna at SITC
Published:
2023-10-31
(Crawled : 14:00)
- biospace.com/
MRNA
S
|
$101.44
-0.55%
-0.55%
2.6M
|
Health Technology
|
36.91%
|
O:
-1.57%
H:
4.44%
C:
4.18%
pre-clinical
mrna
collaboration
platform
Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccine
Published:
2023-09-11
(Crawled : 20:00)
- biospace.com/
MRNA
S
|
$101.44
-0.55%
-0.55%
2.6M
|
Health Technology
|
-5.79%
|
O:
-0.78%
H:
0.42%
C:
-0.94%
covid-19
fda
vaccine
approval
Merck and Moderna Initiate Phase 3 Study Evaluating V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) for Adjuvant Treatment of Patients with Resected High-Risk (Stage IIB-IV) Melanoma
Published:
2023-07-26
(Crawled : 11:00)
- biospace.com/
MRK
|
News
|
$125.78
0.44%
0.0%
8.4M
|
Health Technology
|
16.97%
|
O:
-0.68%
H:
1.13%
C:
0.32%
MRNA
S
|
$101.44
-0.55%
-0.55%
2.6M
|
Health Technology
|
-16.79%
|
O:
0.0%
H:
0.07%
C:
-1.0%
rna-4157
keytruda
melanoma
merck
treatment
study
Moderna Announces Global Regulatory Submissions For Its Respiratory Syncytial Virus (RSV) Vaccine, MRNA-1345
Published:
2023-07-05
(Crawled : 13:00)
- biospace.com/
MRNA
S
|
$101.44
-0.55%
-0.55%
2.6M
|
Health Technology
|
-16.69%
|
O:
0.95%
H:
4.96%
C:
0.53%
mrna-1345
respiratory
global
virus
MODERNA INITIATES ROLLING SUBMISSION TO HEALTH CANADA FOR UPDATED COVID-19 VACCINE
Published:
2023-06-29
(Crawled : 23:00)
- biospace.com/
MRNA
S
|
$101.44
-0.55%
-0.55%
2.6M
|
Health Technology
|
-17.55%
|
O:
-0.41%
H:
0.39%
C:
-0.32%
covid-19
vaccine
health
canada
submission
Global Cancer Vaccine Industry Worth $13.4 Billion by 2030: Use of Nanosensors in Diagnosing Cancer Expected to Create Ample Opportunities for Key Players
Published:
2023-06-27
(Crawled : 10:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
11.2%
|
O:
-1.1%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
9.59%
|
O:
-0.91%
H:
0.56%
C:
-0.5%
MRNA
S
|
$101.44
-0.55%
-0.55%
2.6M
|
Health Technology
|
-15.78%
|
O:
0.03%
H:
0.37%
C:
0.18%
DVAX
|
$11.78
3.88%
3.74%
9.3M
|
Health Technology
|
-8.67%
|
O:
0.08%
H:
1.31%
C:
0.77%
vaccine
expected
cancer
global
Moderna Files for FDA Authorization of Its Updated COVID-19 Vaccine
Published:
2023-06-22
(Crawled : 21:00)
- biospace.com/
MRNA
S
|
$101.44
-0.55%
-0.55%
2.6M
|
Health Technology
|
-16.24%
|
O:
-0.06%
H:
0.26%
C:
-0.43%
covid-19
fda
vaccine
authorization
Promosome LLC Sues Moderna, Pfizer, and BioNTech for COVID-19 Vaccine Patent Infringement
Published:
2023-06-07
(Crawled : 13:00)
- prnewswire.com
MRNA
S
|
$101.44
-0.55%
-0.55%
2.6M
|
Health Technology
|
-20.09%
|
O:
-0.24%
H:
0.39%
C:
-0.77%
covid-19
patent
vaccine
Phase 1/2 Interim Data on Moderna's mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia (PA), Presented at the 2023 ASGCT Annual Meeting
Published:
2023-05-19
(Crawled : 12:00)
- biospace.com/
MRNA
S
|
$101.44
-0.55%
-0.55%
2.6M
|
Health Technology
|
-19.09%
|
O:
0.68%
H:
0.55%
C:
0.05%
rna-3927
mrna
meeting
therapy
Alltrna Engineers tRNA Oligonucleotide with Improved Potency and Activity for In Vivo Readthrough of Premature Termination Codons
Published:
2023-05-18
(Crawled : 13:20)
- biospace.com/
OMGA
|
$2.4
-0.83%
-0.83%
400K
|
|
-73.91%
|
O:
0.0%
H:
0.65%
C:
-4.35%
SANA
|
$7.605
-1.62%
-1.64%
3.4M
|
|
1.74%
|
O:
-1.87%
H:
2.72%
C:
-1.63%
MCRB
|
$0.5671
-2.93%
-3.02%
3.7M
|
Health Technology
|
-88.64%
|
O:
0.61%
H:
0.0%
C:
-2.82%
MRNA
S
|
$101.44
-0.55%
-0.55%
2.6M
|
Health Technology
|
-19.24%
|
O:
0.28%
H:
0.07%
C:
-0.47%
FHTX
|
$5.335
-3.53%
-3.66%
120K
|
Health Technology
|
-19.08%
|
O:
-0.15%
H:
0.0%
C:
-0.15%
EVLO
|
$0.3165
-87.39%
710K
|
Health Technology
|
-88.7%
|
O:
8.57%
H:
1.97%
C:
-1.32%
DNLI
|
$15.98
-3.74%
-3.88%
1.5M
|
Health Technology
|
-46.2%
|
O:
-0.3%
H:
2.6%
C:
2.36%
MODERNA AND NOVOCOL PHARMA ANNOUNCE FILL-FINISH AGREEMENT FOR CANADIAN-MADE MRNA VACCINES
Published:
2023-05-04
(Crawled : 18:00)
- biospace.com/
MRNA
S
|
$101.44
-0.55%
-0.55%
2.6M
|
Health Technology
|
-22.08%
|
O:
2.91%
H:
3.2%
C:
0.3%
pharma
mrna
agreement
Moderna Announces Phase 1/2 Data on mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia (PA) to be Presented at the 2023 ASGCT Annual Meeting
Published:
2023-05-03
(Crawled : 00:00)
- biospace.com/
MRNA
S
|
$101.44
-0.55%
-0.55%
2.6M
|
Health Technology
|
-22.82%
|
O:
-0.67%
H:
1.81%
C:
-0.29%
rna-3927
mrna
meeting
therapy
Moderna and IBM to Explore Quantum Computing and Generative AI for mRNA Science
Published:
2023-04-20
(Crawled : 12:00)
- biospace.com/
IBM
|
News
|
$181.58
0.06%
-0.32%
3M
|
Technology Services
|
43.75%
|
O:
3.03%
H:
0.64%
C:
-2.91%
MRNA
S
|
$101.44
-0.55%
-0.55%
2.6M
|
Health Technology
|
-28.99%
|
O:
-0.99%
H:
2.14%
C:
-0.18%
quantum
mrna
Charles River and Flagship’s Pioneering Medicines Enter Agreement Leveraging AI-Powered Logica with Aim of Creating Novel Therapies for Unmet Medical Needs
Published:
2023-02-16
(Crawled : 17:00)
- biospace.com/
OMGA
|
$2.4
-0.83%
-0.83%
400K
|
|
-56.76%
|
O:
1.62%
H:
4.61%
C:
2.66%
SANA
|
$7.605
-1.62%
-1.64%
3.4M
|
|
64.01%
|
O:
-1.29%
H:
0.0%
C:
-5.9%
CRL
|
$226.78
-0.34%
0.0%
410K
|
Commercial Services
|
-9.84%
|
O:
-1.98%
H:
4.31%
C:
3.13%
MCRB
|
$0.5671
-2.93%
-3.02%
3.7M
|
Health Technology
|
-89.08%
|
O:
-1.75%
H:
3.17%
C:
-0.2%
MRNA
S
|
$101.44
-0.55%
-0.55%
2.6M
|
Health Technology
|
-42.8%
|
O:
-2.37%
H:
1.81%
C:
-0.44%
FHTX
|
$5.335
-3.53%
-3.66%
120K
|
Health Technology
|
-14.93%
|
O:
-2.57%
H:
5.44%
C:
-1.98%
EVLO
|
$0.3165
-87.39%
710K
|
Health Technology
|
-98.03%
|
O:
5.58%
H:
2.0%
C:
-4.13%
DNLI
|
$15.98
-3.74%
-3.88%
1.5M
|
Health Technology
|
-47.14%
|
O:
-1.75%
H:
2.08%
C:
-0.61%
medical
agreement
Moderna Granted FDA Breakthrough Therapy Designation for mRNA-1345, An Investigational Respiratory Syncytial Virus (RSV) Vaccine Candidate
Published:
2023-01-30
(Crawled : 13:00)
- biospace.com/
MRNA
S
|
$101.44
-0.55%
-0.55%
2.6M
|
Health Technology
|
-46.44%
|
O:
-1.12%
H:
0.19%
C:
-3.4%
rna-1345
fda
designation
candidate
vaccine
respiratory
virus
granted
therapy
EMA Committee for Medicinal Products for Human Use (CHMP) Recommends the Use of Moderna’s BA.1 Targeting Bivalent COVID-19 Booster in Children (6-11 Years) In the European Union
Published:
2022-12-16
(Crawled : 18:00)
- biospace.com/
MRNA
S
|
$101.44
-0.55%
-0.55%
2.6M
|
Health Technology
|
-51.07%
|
O:
-0.42%
H:
1.69%
C:
-6.34%
covid-19
children
ema
← Previous
1
2
3
4
5
6
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.